Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) Study of Malaria in Pediatric Patients in Canada: A Retrospective Review from 2014 to 2023

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 552111

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2025
  • Known Financial Commitments (USD)

    $1,214.79
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Geraldine Huynh
  • Research Location

    Canada
  • Lead Research Institution

    University of Alberta
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures
  • Research Subcategory

    Indirect health impacts
  • Special Interest Tags

    N/A
  • Study Type

    Clinical
  • Clinical Trial Details

    Not applicable
  • Broad Policy Alignment

    Pending
  • Age Group

    Children (1 year to 12 years)
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract

Objective: We studied malaria in Canadian children between 2014-2023, focusing on how often it occurs, who is affected, how severe it is, and how COVID-19 travel restrictions influenced cases. Design/Setting: We reviewed records from 11 children's hospitals across Canada. Participants: 431 children under 18 years old with laboratory-confirmed malaria. Results: The average age was 8 years; just over half were boys. Most children were born outside Canada (73%) and almost all had recently traveled to malaria-endemic regions (98%). Travel was often related to moving to Canada as migrants/refugees (56%) or visiting family abroad (38%). Few families sought pre-travel medical advice (36%), received malaria prevention prescriptions (33%), or followed them fully (23%). The most dangerous malaria parasite, Plasmodium falciparum, caused most infections (85%). Severe malaria occurred in nearly 40% of children, with 14% needing intensive care. One child died from unrelated causes. Use of the medicine artesunate was common, though some children later developed delayed anemia. Case numbers fell sharply during COVID-19 travel restrictions but rose again after 2022. The types of malaria parasites did not change, and delays in diagnosis remained frequent. Kidney injury was rarely detected using current Canadian guidelines (5%) but was common when international criteria were applied (53%). Only falciparum malaria clearly predicted severe illness. Conclusions: Malaria in Canada mostly affects newcomer families and those visiting relatives abroad, and often results in serious illness needing intensive care. Our findings show gaps in timely diagnosis, limited prevention before travel, and under-recognition of kidney complications with current Canadian guidelines. Updates to pediatric care guidance and stronger efforts to improve pre-travel counseling and malaria prevention are urgently needed.